- © 2010 Marshfield Clinic
Association of B-Type Natriuretic Peptide Levels With Estimated Glomerular Filtration Rate and Congestive Heart Failure
- Carmen L. Wiley, PhD*,
- Sean P. Switzer, DO†,
- Richard L. Berg, MS‡,
- Ingrid Glurich, PhD§ and
- Richard A. Dart, MD#
- *Providence Sacred Heart Medical Center, Laboratory Medicine and Pathology, Spokane, WA;
- †CentaCare Health System, St. Cloud, MN;
- ‡Biomedical Informatics Research Center and
- §Office of Scientific Writing and Publication, Marshfield Clinic Research Foundation, Marshfield, WI;
- #Department of Nephrology, Marshfield Clinic, Marshfield, WI
- Corresponding Author:
Carmen L. Wiley, PhD, Providence Sacred Heart Medical Center, Laboratory Medicine and Pathology, 101 West 8th Avenue, Spokane, WA 99220-2555, Tel: 509-474-4404, Fax: 509-474-4740, E-mail: carmen.wiley{at}providence.org
Abstract
Background: The causes of elevated B-Type natriuretic peptide (BNP) levels are multifactorial. Renal dysfunction has been shown to affect BNP levels in some studies and the diagnostic value of BNP levels in the presence of chronic kidney disease has been questioned. Prior studies have involved small patient populations with variable outcomes noted. This study evaluated the association of BNP levels with an estimated glomerular filtration rate (eGFR) and presence or absence of congestive heart failure (CHF).
Methods: A retrospective, cross-sectional study in which medical records were electronically screened, identified patients with a BNP level and serum creatinine measurement on the same day between December 2002 and March 2006.
Results: Of 1739 eligible patients, 537 were positive for CHF and 1202 were negative for CHF by our criteria. There was a clear trend for BNP to be higher with the advancement of CHF, as determined by New York Heart Association (NYHA) classification (P<0.001). Median BNP levels increased from 65 pg/mL in patients without CHF to 496 pg/mL in patients with NYHA class IV CHF (P <0.001), and there was a strong inverse association with eGFR (P <0.001).
Conclusion: BNP levels show a strong inverse association with eGFR in both CHF and non-CHF patients. Currently best practice at most institutions involves use of BNP cutoff diagnostic levels not adjusted for eGFR. The data presented underlines that eGFR is a significant confounder of BNP measurement especially when renal status is compromised and interpretation of clinical significance in the presence of elevated BNP measures should take renal status into consideration.
